In 3 weeks this spring: Taylor Swift directed royalties to ETAF. Real Housewives pressed Congress on ADAP cuts. EJAF raised $10.6M. Ciara re-recorded a hit for PrEP awareness. Celebrity HIV advocacy isn't new — and the policy stakes have never been higher. buff.ly/quIoQ4u #HIV #TaylorSwift

Public health programs exist to serve patients—not corporate balance sheets. Minnesota's 340B data tells the story: $120M+ to middlemen while some safety-net providers posted negative 340B revenue. We need accountability. Now. Read more: buff.ly/oPjCmmG #340B #DrugPricing #HealthcareAccess

Louisiana must reject #SB401 and save patients from hardships imposed by Prescription Drug Affordability Boards (PDABs). Otherwise, patients will suffer from flawed policies like Upper Payment Limits (UPLs) — price caps that limit medication access and supply and increase out-of-pocket costs.

Louisiana SB 401 puts a PDAB between patients and care decisions that affect their lives. Patients lose their voice, while insurance practices that determine what people actually pay at the pharmacy go untouched. Robert Allain III & Royce Duplessis, oppose SB 401 for the patients' sake. #lalege

New data show a single-tablet regimen could change everything for long-term #HIV survivors still managing multi-pill regimens because of decades of drug resistance. The science is ready. The question is whether Medicare and formulary systems will let it reach them. Read more: buff.ly/6t5ccrt

Contract pharmacy expansion does not translate into improved patient care. Amy Hinojosa, CEO and president of @MANANational, explains how the misuse of #340B impacts Coloradans. Read more via @NewslineCO >> buff.ly/OaA3KlV

18 states restrict ADAP access through prior auth and formulary cuts to solve budget crises—a strategy that costs more, drives resistance, and concentrates harm on vulnerable communities. Our analysis examines the false economy of rationing life. #HIV #ADAP

Thank you to @HouseCommerce and Chairman @RepGuthrie for examining the role that hospitals play in high costs for patients. We urge you to consider the patient perspective during tomorrow’s hearing. More evidence continues to come out about outsized hospital spending within #340B. buff.ly/RFTYIjS

This piece by @blackdoctor_org makes a great point: reforms are not rollbacks. Millions of underserved patients rely on #340B to access affordable health care. They deserve to know how the program is operating to adhere to health equity standards. Read more >> buff.ly/vZHRjz5

Average family health insurance premiums hit $26,993 in 2025, with workers contributing $6,850. From 1988-2019, families lost $125,340 in earnings to rising premiums. Our analysis examines the hidden pay cut eroding worker compensation. #HealthInsurance buff.ly/LhqS5bz

Americans of all backgrounds and income statuses are victim to delays and denials imposed by health insurance giants. Months before his death, actor Eric Dane was approved for his #ALS treatment after going through two appeal processes. Read more via @BuzzFeed >> buff.ly/illiXkl

Health insurance premiums exceeded the threshold of affordable coverage in five states: West Virginia, Mississippi, North Carolina, Florida and Louisiana. Of that list, and in the US overall, Louisiana families face the highest costs. Read more via @axios >> buff.ly/riU2rH3

Thank you to @FLSenate for passing the Health Care Coverage bill by Rep. @jasonbrodeur, getting us closer to ensuring low-income Floridians living with HIV/AIDS can access lifesaving treatments. We appreciate the measure also holds FDOH accountable for program sustainability. buff.ly/xd76zCc

We cannot miss this opportunity to ensure Floridians living with #HIV can access lifesaving antiretroviral treatment. @myflhouse we urge you to pass the Health Care Coverage bill (SB 1760) to provide bridge funding for the state's AIDS Drug Assistance Program (#ADAP). buff.ly/UKMF57Q

Hospitals participating in #340B are more likely than non-340B hospitals to aggressively pursue patients with medical debt. Charity care is meant to help patients, not be misused as a vehicle to garnish their wages and sue them in the name of profit. Read more via @ncl_tweets >> buff.ly/AMO8zZm

Patients are sharing their stories about the impact of expired #ACA subsidies. One patient is now paying $483 per month for insurance, up from $162 in 2025 – “a difference of nearly $3,900 per year.” Read more via @CNBC >> buff.ly/D2DPofz

CROI 2026 showcased lenacapavir PrEP, long-acting treatment options, and cure progress—but 47% of clinics globally reported HIV service disruptions from PEPFAR and NIH cuts. Our analysis: the tools are here, the infrastructure is collapsing. #CROI2026 #HIV

CANN board member Ryan Carpenter urges Washington state legislators to reject unchecked #340b expansion. We need true oversight and accountability at the federal level, not ill-informed state approaches. Read more via @thenewstribune >> buff.ly/HBP8XkR

Why do massive insurers, especially one that is among the top ten most profitable companies in the world, deny mental health care? To retain profits at the expense of patient care. Read more via @ProPublica >> buff.ly/ytlUkFB

What could be scarier than ghosts? Insurance ghost networks – where they list providers who do not accept insurance, duping patients into believing “there are more options for care than actually exist.” Read more via @ProPublica >> buff.ly/an6RHgp

ADAPs achieved 87% viral suppression serving 257,644 people in 2024, but 340B rebates now fund 52% of budgets—and multiple federal policies are eroding that revenue while H.R. 1 Medicaid cuts will surge demand. Our analysis examines the crisis ahead. #ADAP #HIV

CANN's strong digital footprint helps shape patient-centered policies, and so do our real footprints as we work in-person. This week, we had the pleasure of collaborating with incredible partners like Dr. Ifeoma Udoh of @blkwomenshealth to ensure health programs serve those most in need.

As we’ve said before, those who have nothing to hide should not be afraid of transparency. AIDS Drug Assistance Programs (ADAPs) have long used the rebate model – if they can do so under size constraints and other limitations, so can large systems. Read more >> buff.ly/wMjSPiC

The inimitable @sallypipes points out that #340B growth is funneled into private investments and financial portfolios — not patients. Read more via @PacificResearch>> buff.ly/ZQpd9cY

Warren and Hawley introduced the Break Up Big Medicine Act, forcing structural separation of healthcare conglomerates that own insurers, PBMs, pharmacies, and physician practices. Our analysis examines what the bill does and what it misses. #PBMReform

CMS added Biktarvy—the only 1A DHHS-recommended HIV regimen with no viral load restrictions—to Medicare drug price negotiations. Our analysis examines why including infectious disease drugs and Part B medications creates unique access risks. #HIV #PublicHealth

Reminder, CANN will always put patients first. The 340B program was not designed for covered entities and third parties to cosplay Wolf of Wall Street — and we will always stand on that. Our receipts are public. If health system lookalikes and consulting firms have nothing to hide, prove it!

HHS announced $100 million for addiction treatment while calling harm reduction "non-effective"—despite VA data showing syringe programs decrease HIV/HCV infections by 67%. Our analysis examines the contradictions in American addiction policy. #HarmReduction #SubstanceUse

Our President & CEO Jen Laws' latest opinion piece dissects the problems with state and federal policy proposals that would enable the unchecked expansion of #340B contract pharmacies.

Statutory language makes clear that the 340B program’s intended beneficiaries are patients, not covered entities. Yet, state-enacted laws do not require transparency as to how 340B revenue is used, nor do they improve program accountability. buff.ly/D7Qh1RC

As our friends at @TruthRX so aptly put it, "Everyone wants to write PBM reform bills but the laws need to have the right set of teeth." WV investigated PBMs and enacted consequences: -Repayment to pharmacies. -Interest on late payments. -A corrective action plan. Read more >> buff.ly/6LRuqBy

CANN released two new policy briefs related to #340B. The first about conflicts between federal 340B reform proposals & individual states’ actions; the second presents data showing that states’ actions have not meaningfully improved patient access or affordability. Read more >> buff.ly/zgC1DdZ

CANN published a new case study examining a FQHC in WA and their #340B abuses. 💉💰In 2024, Sea Mar purchased drugs for $5 million through 340B and marked prices up over 10x to $50 million. 🗒️🖊️47 citations from the Accreditation Council for Graduate Medical Education. Read more >> buff.ly/d9z24Nn

Congress rejected $1.7 billion in proposed HIV cuts but flat funding won't end the epidemic. Our analysis examines FY2026 appropriations: Ryan White preserved at $2.6B, first major PBM reforms in 20 years, but harm reduction evidence ignored. #HIV #RyanWhite

South Florida lawmakers urge DeSantis to restore drug funding for low-income HIV/AIDS patients. The sudden change in income eligibility requirements was made without public input - putting Floridians at risk. Read more >> buff.ly/uOChbUy

.@CMSGov must put our needs as patients first in the upcoming cycle of Medicare Drug Price Negotiations in 2028. This public engagement session is our opportunity to share experiences and provide expertise. Sessions will be held in Spring 2026. Register here >> buff.ly/4Q2xBSB

Florida is cutting ADAP income eligibility from 400% to 130% of poverty, eliminating insurance assistance, and removing Biktarvy from formulary—threatening 16,000 people with treatment disruption. Our analysis examines the stakes and the failures. #HIV #ADAP

340B was created to stretch resources for patients, but large hospital systems have turned it into a financial engine with no accountability. Our new Patient Advocacy Toolbox equips patients with tools to reclaim the program's promise. #340B #PatientAccess buff.ly/H7Nazkd

Because of rapid response efforts by our friends at @AIDSAlabama & others across the country, #SAMHSA grants are claimed to be restored. While we wait for official notices, we want to thank advocates & legislators who urgently sounded the alarm. Read more via @RollCall >> buff.ly/BJTCc8U

The upcoming Medicaid work requirements offer unemployment hardship exceptions across rural and urban areas, but its scope is limited. According to @KFFHealthNews, just 7% of counties meet the high unemployment criteria with 7% of enrollees living in these counties. buff.ly/i6ispeh

New #Medicaid work programs will negatively impact states throughout the country, particularly those serving a majority of #rural patients who often have limited internet access and jobs with fluctuating hours. We need large hospital systems to pay their fair-share. buff.ly/zjSrC5T

Efforts to prevent HIV transmission in the US are paying off – literally. From 2017-2021, 9,000 new HIV infections were prevented, saving $5 billion in lifetime medical costs. Despite HIV prevention programs being some of the most effective dollars we spend, they are under threat.

CANN's CEO reflects on 2025's transformative year and announces organizational evolution for 2026: staff expansions, re-vamped Community Roundtable events, and a paradigm shift from institutional comfort to nimble, responsive advocacy. #HIV #PatientAdvocacy #HealthcareReform

We know large nonprofit hospitals sue low-income patients. Instead of providing charity care, they funnel profits into self-serving initiatives. Sadly, this phenomenon is trickling down to bad actors in community health centers and #FQHCs. buff.ly/0gA5KE1

Pharmacists are instrumental in patient-centered care. Their meticulous, vigilant approach to dosages, contraindications, counseling, and handling insurance claims helps people take control of their lives. buff.ly/S8PQ0I2

In December, CANN submitted public comment in support of continuing the State Unintentional Drug Overdose Reporting System (SUDORS). Read more >> buff.ly/bhws1VN

TikTok star Mainly Mannie received an outpouring of love and support after revealing his #HIV diagnosis and recent struggles with #mentalhealth. Read more via @them >> buff.ly/PWy4j36

Earlier this month, CANN submitted public comment in support of continuing and strengthening the National HIV Surveillance System (NHSS). Studies show that the U.S. is not going to meet the Ending the HIV Epidemic goal of a 90% reduction in new HIV infections by 2030. buff.ly/yzwcdPu

The #holidays are festive and fast-paced, but we also slow down, and honor our connections. CANN’s year-end blog post – authored by our friend Kristy Kibler, CEO of @LupusColorado – recounts forging a partnership to spark powerful change for patients living with #HIV, viral #hepatitis, and #lupus.

Join our CEO Jen Laws (@PolicyCandy) and colleagues from @CSROAdvocacy and @TruthRx as they discuss Virginia's proposed #340B legislation and impact on patients. Tune in on Monday, December 15 at 2pm ET. Register here: buff.ly/eO9cMZl